Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 1/20 | 0.34 |
| ▸ | RNASE1 | P07998 | 1/20 | 0.32 |
| ▸ | TK1 | P04183 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31685730 | 0.81 | LMNA (0.44) | TK1 | |
| SCHEMBL31685487 | 0.79 | TYMS (0.46) | — | |
| SCHEMBL31685513 | 0.77 | ADORA1 (0.42) | — | |
| SCHEMBL31685300 | 0.73 | P2RY1 (0.41) | P2RY1 | |
| SCHEMBL31685646 | 0.72 | TK1 (0.44) | P2RY1RNASE1TK1 | |
| SCHEMBL31685660 | 0.70 | POLB (0.41) | P2RY1RNASE1TK1POLB | |
| SCHEMBL31685710 | 0.69 | LMNA (0.42) | POLB | |
| SCHEMBL10331938 | 0.69 | RNASE1 (0.45) | P2RY1RNASE1TK1POLB | |
| SCHEMBL6517103 | 0.69 | RNASE1 (0.45) | P2RY1RNASE1TK1POLB | |
| SCHEMBL31685407 | 0.69 | POLB (0.39) | P2RY1RNASE1TK1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | SYNCRIP, SNRPA, RNASE1 | P2RY1 2249/4885RNASE1 3/4885TK1 950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.